European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

Thank you. Good morning, and welcome to the Palatin first quarter fiscal year 2025 call. I'm Dr. Carl Spana, CEO and President of Palatin. With me on the call today is Steve Wills, Palatin's Chief ...